H.C. Wainwright Upgrades Trillium Therapeutics (TRIL) to Buy
H.C. Wainwright analyst Swayampakula Ramakanth upgraded Trillium Therapeutics (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
